Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclopentanes | 11 | 2015 | 19 | 3.210 |
Why?
|
| Cyclization | 26 | 2016 | 47 | 2.600 |
Why?
|
| Palladium | 6 | 2017 | 27 | 2.330 |
Why?
|
| Ketones | 7 | 2015 | 17 | 1.870 |
Why?
|
| Fluorenes | 2 | 2022 | 26 | 1.720 |
Why?
|
| Stereoisomerism | 21 | 2017 | 162 | 1.680 |
Why?
|
| Alkadienes | 4 | 2013 | 6 | 1.420 |
Why?
|
| Indicators and Reagents | 5 | 2022 | 57 | 1.130 |
Why?
|
| Acids | 2 | 2016 | 15 | 1.130 |
Why?
|
| Benzofurans | 2 | 2016 | 19 | 1.110 |
Why?
|
| 4-Butyrolactone | 2 | 2015 | 11 | 1.080 |
Why?
|
| Catalysis | 12 | 2017 | 162 | 1.070 |
Why?
|
| Cannabinoids | 7 | 2021 | 54 | 0.960 |
Why?
|
| Biological Products | 2 | 2015 | 67 | 0.910 |
Why?
|
| Fluorine | 1 | 2022 | 16 | 0.890 |
Why?
|
| Chrysenes | 1 | 2022 | 5 | 0.860 |
Why?
|
| Ethers | 5 | 2013 | 19 | 0.750 |
Why?
|
| Receptor, Cannabinoid, CB2 | 7 | 2021 | 33 | 0.710 |
Why?
|
| Molecular Structure | 11 | 2021 | 467 | 0.670 |
Why?
|
| Azetidines | 3 | 2023 | 7 | 0.660 |
Why?
|
| Indoles | 2 | 2008 | 154 | 0.570 |
Why?
|
| Receptor, Cannabinoid, CB1 | 6 | 2021 | 40 | 0.570 |
Why?
|
| Amines | 3 | 2015 | 38 | 0.560 |
Why?
|
| Dioxolanes | 1 | 2015 | 2 | 0.540 |
Why?
|
| Oceans and Seas | 1 | 2015 | 14 | 0.540 |
Why?
|
| Prostaglandins | 1 | 2015 | 25 | 0.530 |
Why?
|
| Methanol | 1 | 2015 | 18 | 0.530 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 137 | 0.520 |
Why?
|
| Imines | 2 | 2013 | 9 | 0.500 |
Why?
|
| Oxidation-Reduction | 5 | 2022 | 407 | 0.490 |
Why?
|
| Alkenes | 1 | 2013 | 15 | 0.470 |
Why?
|
| Carbon | 1 | 2014 | 95 | 0.460 |
Why?
|
| Oxides | 1 | 2013 | 89 | 0.440 |
Why?
|
| STAT3 Transcription Factor | 4 | 2023 | 80 | 0.420 |
Why?
|
| Azirines | 1 | 2010 | 2 | 0.380 |
Why?
|
| Aza Compounds | 1 | 2010 | 10 | 0.380 |
Why?
|
| Organic Chemicals | 1 | 2010 | 35 | 0.370 |
Why?
|
| Silicon Dioxide | 2 | 2005 | 33 | 0.330 |
Why?
|
| Molecular Conformation | 6 | 2017 | 150 | 0.330 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2010 | 10 | 0.320 |
Why?
|
| Adamantane | 3 | 2015 | 8 | 0.310 |
Why?
|
| Receptors, Drug | 2 | 2003 | 56 | 0.280 |
Why?
|
| Receptors, Cannabinoid | 4 | 2015 | 26 | 0.280 |
Why?
|
| Ligands | 5 | 2017 | 317 | 0.270 |
Why?
|
| Molecular Probes | 3 | 2015 | 23 | 0.260 |
Why?
|
| Structure-Activity Relationship | 7 | 2021 | 376 | 0.250 |
Why?
|
| Salicylic Acid | 1 | 2023 | 6 | 0.240 |
Why?
|
| Vinyl Compounds | 1 | 2003 | 5 | 0.230 |
Why?
|
| Fluorides | 1 | 2022 | 19 | 0.220 |
Why?
|
| Furans | 1 | 2003 | 34 | 0.220 |
Why?
|
| Allyl Compounds | 1 | 2003 | 47 | 0.220 |
Why?
|
| Peptides, Cyclic | 1 | 2002 | 30 | 0.210 |
Why?
|
| Esters | 2 | 2012 | 28 | 0.200 |
Why?
|
| Receptors, Calcitriol | 1 | 2021 | 59 | 0.190 |
Why?
|
| Models, Molecular | 4 | 2014 | 751 | 0.180 |
Why?
|
| Amides | 3 | 2020 | 66 | 0.170 |
Why?
|
| Up-Regulation | 1 | 2021 | 490 | 0.170 |
Why?
|
| Cannabinol | 1 | 2017 | 1 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 303 | 0.150 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2007 | 35 | 0.150 |
Why?
|
| Deoxyglucose | 2 | 2007 | 19 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2022 | 874 | 0.140 |
Why?
|
| Thiourea | 1 | 2015 | 4 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2007 | 281 | 0.140 |
Why?
|
| Benzoates | 1 | 2015 | 15 | 0.140 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 30 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 756 | 0.130 |
Why?
|
| Glioma | 1 | 2015 | 76 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 105 | 0.120 |
Why?
|
| Alcohols | 1 | 2013 | 12 | 0.120 |
Why?
|
| Alkynes | 1 | 2013 | 49 | 0.120 |
Why?
|
| Isomerism | 2 | 2003 | 62 | 0.120 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 2128 | 0.120 |
Why?
|
| Benzopyrans | 1 | 2012 | 10 | 0.110 |
Why?
|
| Thiophenes | 1 | 2012 | 31 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 342 | 0.100 |
Why?
|
| Lithium Compounds | 1 | 2009 | 3 | 0.090 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 237 | 0.090 |
Why?
|
| Gases | 1 | 2009 | 24 | 0.090 |
Why?
|
| Animals | 7 | 2022 | 14307 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2022 | 878 | 0.080 |
Why?
|
| Protons | 1 | 2008 | 80 | 0.080 |
Why?
|
| Cyclohexylamines | 1 | 2007 | 12 | 0.080 |
Why?
|
| Mice | 5 | 2022 | 5668 | 0.080 |
Why?
|
| Crystallization | 1 | 2007 | 82 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 129 | 0.070 |
Why?
|
| Protein Binding | 3 | 2020 | 913 | 0.070 |
Why?
|
| Humans | 10 | 2022 | 34853 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 984 | 0.070 |
Why?
|
| Morpholines | 1 | 2006 | 65 | 0.070 |
Why?
|
| Alkylation | 1 | 2005 | 11 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2007 | 201 | 0.070 |
Why?
|
| Gels | 1 | 2005 | 41 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 255 | 0.070 |
Why?
|
| Rats | 4 | 2017 | 3261 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1426 | 0.060 |
Why?
|
| Apoptosis | 2 | 2022 | 1317 | 0.060 |
Why?
|
| Radioligand Assay | 2 | 2015 | 61 | 0.060 |
Why?
|
| Cations | 1 | 2003 | 44 | 0.060 |
Why?
|
| Phenylcarbamates | 1 | 2002 | 2 | 0.060 |
Why?
|
| Amylose | 1 | 2002 | 5 | 0.060 |
Why?
|
| Isotope Labeling | 1 | 2003 | 27 | 0.060 |
Why?
|
| Iodine Radioisotopes | 1 | 2003 | 33 | 0.060 |
Why?
|
| Carbamates | 1 | 2002 | 11 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1149 | 0.060 |
Why?
|
| Mandelic Acids | 1 | 2002 | 1 | 0.060 |
Why?
|
| Depsipeptides | 1 | 2002 | 7 | 0.050 |
Why?
|
| Cyanobacteria | 1 | 2002 | 23 | 0.050 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2021 | 21 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2021 | 11 | 0.050 |
Why?
|
| beta Catenin | 1 | 2021 | 46 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 81 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2002 | 406 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 109 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 269 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2022 | 1802 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2021 | 322 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 247 | 0.050 |
Why?
|
| Base Sequence | 1 | 2021 | 932 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 707 | 0.040 |
Why?
|
| DNA | 1 | 2020 | 549 | 0.040 |
Why?
|
| Models, Biological | 1 | 2021 | 642 | 0.040 |
Why?
|
| Cell Survival | 1 | 2020 | 818 | 0.040 |
Why?
|
| Cell Movement | 1 | 2021 | 545 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 781 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 60 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2015 | 119 | 0.030 |
Why?
|
| Molecular Probe Techniques | 1 | 2015 | 7 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 323 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 496 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 360 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 116 | 0.030 |
Why?
|
| Binding Sites | 1 | 2012 | 597 | 0.020 |
Why?
|
| Solutions | 1 | 2009 | 60 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 102 | 0.020 |
Why?
|
| Female | 2 | 2021 | 19873 | 0.020 |
Why?
|
| Quantum Theory | 1 | 2009 | 76 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 68 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2009 | 207 | 0.020 |
Why?
|
| Polymers | 1 | 2009 | 117 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 9642 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1289 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2002 | 21 | 0.010 |
Why?
|
| Membranes | 1 | 2002 | 18 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 25 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 1268 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 192 | 0.010 |
Why?
|
| Kidney | 1 | 2002 | 322 | 0.010 |
Why?
|
| Male | 1 | 2015 | 18870 | 0.010 |
Why?
|